News

Press Releases

Viscira® Leverages Oculus Rift to Deliver Unique Virtual Reality (VR) Solutions

Facebook’s recent $2 billion acquisition of Oculus VR is a sure indicator of the potential for virtual reality technology to benefit other areas outside of gaming.(1) One of those areas is healthcare, where Viscira has certainly recognized the promise of VR capabilities to impact the future of healthcare communication. While many are familiar with the use of virtual reality technology by the gaming industry, most are not as aware of its potential within the medical industry.

Viscira, a leading provider of interactive, new-media communication solutions and software products for the life sciences industry, has been capitalizing on this opportunity by offering VR solutions for its clients that communicate healthcare information in very personal and immersive ways. One recent example was the development of a VR solution for a client using the Oculus Rift to simulate the impact of schizophrenia on a patient. Donning the Oculus Rift goggles, a healthcare professional, caregiver or other user becomes completely immersed in a 3D environment that offers a full visual and auditory experience of what it might be like to be a schizophrenic patient.

The intent with this simulated experience is for the user to develop more empathy for the patient and the various challenges they face. This in turn helps to reinforce the need for active, consistent patient support and ongoing medication adherence, among other patient success factors. It also helps to demonstrate the ability for patients with the disease to still lead active, quality lives with the right plan in place.

Previously, Viscira also developed a virtual reality exhibit called “EyeMac” that enabled physicians to simulate the experience of having neovascular (wet) age-related macular degeneration (AMD). Physicians used special goggles to immerse themselves in several virtual scenarios from a first-person, patient perspective. Additionally, the module generated data to help physicians better treat this eye disease.

Dave Gulezian, President & CEO of Viscira, commented on the use of VR for developing innovative digital solutions for its clients. “From early in our company’s development, we recognized the potential for VR technology to change the way we communicate healthcare information. Our ongoing focus on utilizing cutting-edge technology, including the Oculus Rift, enables us to continue to provide unique and differentiated products for our industry.”

Viscira’s virtual and augmented reality solutions are just one example of many innovative, interactive software applications and new-media programs the company offers which range from their Prospero™ Online Speaker Portal platform to 3D mechanism-of-action (MOA) animations to interactive visual aids and other iPad applications. Viscira’s strategic approach, combined with its delivery of cutting-edge products, has resulted in an impressive roster of industry-leading clients, including Amgen, Johnson & Johnson, Genentech, Pfizer, Novartis and Lilly.

1. Facebook, Oculus, and Businesses' Thirst for Virtual Reality. http://www.forbes.com/sites/leoking 3/30/14

Click here to read the full article

Viscira® Announces European Expansion

Viscira®, a leading provider of interactive, new-media communication solutions and software products for the life sciences industry, today announced the opening of a new office in London. This destination will serve as a launching point for the company to expand its business in the top five European markets (France, Germany, Italy, Spain, and the United Kingdom) and beyond.

This move represents a logical next step given Viscira’s rapid growth and its current base of major global life science clients, including Roche, Bristol-Myers Squibb, Novartis and AbbVie. It also follows the increasing use of digital technology and channels by European pharmaceutical companies.

According to a recent report issued by Cegedim Strategic Data, European pharmaceutical companies, including those from the UK, Germany, France, Spain and Italy, raised their aggregate spending on digital channels by almost 40% from 2011 to 2012.1 This growth is expected to continue.

“Our expansion in Europe is a major step for the company. Although we have already been doing a meaningful amount of work in the EU, this move will enable us to better serve our clients there and help to further build our business,” explained Dave Gulezian, President & CEO of Viscira. “More and more of the work we are doing for our clients includes a global component and we only expect this need to grow.”

Nicole Tulli, Director of Global Business Development, will be relocating to London to spearhead Viscira’s efforts in the EU. Nicole has been with the company since 2010 and has helped to develop innovative digital solutions for top-tier pharmaceutical companies such as Bristol-Myers Squibb, Teva, and AstraZeneca.

“I am very excited to have this opportunity to lead Viscira’s expansion into the European market. I’m confident that our unique and sophisticated digital solutions, along with our ability to develop high-impact digital strategies, will enable us to provide significant value to European life science clients,” Tulli commented. 

Click here to read the full article 

Viscira® Welcomes New Vice President of Client Services

Viscira®,a leading provider of interactive, new-media communication and technology solutions for the life sciences industry, is proud to announce that Kimberly Davis-Wells has rejoined the company as its new Vice President of Client Services. Davis-Wells will be responsible for leading Viscira’s account management and medical content functions, providing oversight for digital strategy development and tactical program execution across the company’s diverse base of domestic and international clients. She will also collaborate with the other members of the Viscira executive team to help shape strategic direction for the company and contribute to new product development efforts.

Kimberly brings a wealth of relevant industry experience to the position, including a previous role at Viscira as a Director of Account Management. She has also held senior-level account management positions at pharmaceutical marketing and digital agencies, including Havas Worldwide, Kane & Finkel, and Publicis Modem. Overall, Kimberly has more than 15 years of experience building major brands and delivering award-winning digital and marketing programs for top-tier life science companies such as Genentech, Amgen, AbbVie, and Pfizer.

Kimberly commented, "I'm thrilled to rejoin the Viscira team and am very excited about the level of technology leadership and creative thinking happening within the company. I’m looking forward to further enhancing Viscira’s client services function to build even deeper relationships with our clients as their preferred strategic technology partner and digital agency of record."

Dave Gulezian, President and CEO of Viscira said, “We are very happy to welcome Kimberly back to the Viscira family. She is an extremely talented pharma marketing professional and manager who is highly regarded by clients across the industry. I’m confident that Kimberly will help strengthen our leadership position within the digital space as we continue to innovate and provide additional value for our clients.”

Click here to read the full article

Viscira’s 3D Medical Animation Capabilities Showcased by The Foundry

Viscira®, a leading provider of interactive, new-media communication and technology solutions for the life sciences industry, is featured in a new client testimonial video launched by The Foundry. The video was recently unveiled alongside the company’s re-branded website.

The piece promotes the key features and benefits of MODO, a 3D modeling, painting, animation and rendering software solution, and includes an interview with Hagop (Kane) Kaneboughazian, Viscira’s Vice President of Animation, as well as samples of Viscira’s industry-leading 3D animation work.

(Click here to view the full interview) 

“We created this video to showcase the many ways that MODO is used to create amazing visuals in a wide range of industries, “explained Bill Collis, CEO of The Foundry. “Viscira is a particularly interesting example of a MODO client and we are thrilled to highlight their work. The incredibly high quality and striking 3D medical animation they are creating is a testament to both the creative talent at Viscira and the innovative MODO toolsets.”

The animation team at Viscira has delivered hundreds of programs since the company’s inception in 2007, and is continually raising the bar for medical animation production. Viscira’s animations are deployed via a variety of channels including iPad, web, conventions and broadcast. The company also delivers fully interactive, stereoscopic, and augmented reality versions of these animations.

The artists at Viscira come from a wide range of backgrounds. Many are veterans from the film industry who have worked on movies that include Antz, Jimmy Neutron and Alice in Wonderland. Their experience includes prior work at leading film production and visual effects companies like Pixar and Lucasfilm.

Viscira’s 3D animations can be customized for healthcare professionals, as well as for patients. In addition to Viscira’s in-house 3D team, multiple functions contribute to the company’s award winning animations including medical writers, concept artists, storyboard artists and motion graphics developers.

Viscira’s next-generation 3D animations are just one of many new-media solutions and software products the company offers, which range from a robust online speaker portal (OSP) platform to dynamic enhanced video presentation modules, and from interactive medical case study programs to high-impact sales and educational applications for the iPad.

Click here to read the full article

News by Year Press Releases - News page